My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Corvus Pharmaceuticals, Inc. - Common Stock (NQ:CRVS)

7.770 +0.070 (+0.91%)

Streaming Delayed Price Updated: 12:33 PM EST, Dec 29, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Corvus Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

Corvus Pharmaceuticals Inc (NASDAQ:CRVS) Reports Narrower-Than-Expected Q2 2025 Loss, Shares Rise on Clinical Progress ↗

August 07, 2025

Corvus Pharmaceuticals reported a narrower Q2 2025 loss of $0.10 per share, beating estimates, with shares rising 5.8% after-hours. Positive Phase 1 data for soquelitinib in atopic dermatitis boosted...

Via Chartmill

Corvus (CRVS) Q2 Loss Beats Estimates ↗

August 07, 2025

Via The Motley Fool

Topics Intellectual Property

Earnings Scheduled For August 7, 2025 ↗

August 07, 2025

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 09, 2025

Via Benzinga

Corvus Gets Price Target Hike From Oppenheimer On Positive Drug Trial Results: Retail’s Pleased ↗

May 09, 2025

Corvus announced new interim data from its Phase 1 clinical trial evaluating Soquelitinib in patients with moderate to severe atopic dermatitis.

Via Stocktwits

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

An Overview of Corvus Pharma's Earnings ↗

November 11, 2024

Via Benzinga

Why Is Corvus Pharmaceuticals Stock Soaring On Friday? ↗

May 09, 2025

Corvus Pharmaceuticals, Inc.(NASDAQ:CRVS) on Thursday released new interim data from the Phase 1 clinical trial evaluating ...

Via Benzinga

Wondering what's happening in today's pre-market session? ↗

May 09, 2025

Let's have a look at what is happening on the US markets before the opening bell on Friday. Below you can find the top gainers and losers in today's pre-market session.

Via Chartmill

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

May 09, 2025

Via Benzinga

Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗

May 09, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

May 08, 2025

Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 08, 2025

Via Benzinga

These stocks are gapping in today's session ↗

March 26, 2025

Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Wednesday. Let's explore the market movements and identify the stocks with significant gaps.

Via Chartmill

Corvus Pharma Stock Dips On Bigger-Than-Feared Q4 Loss, But Retail’s Faith Grows Stronger ↗

March 25, 2025

Research and development expenses in the reported quarter rose by $2 million, primarily due to increased spending on the soquelitinib clinical trial for T-cell lymphoma.

Via Stocktwits

Earnings Scheduled For March 25, 2025 ↗

March 25, 2025

Via Benzinga

This Kopin Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

January 02, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 18, 2024

Via Benzinga

Why Is Corvus Pharmaceuticals Stock Trading Lower On Wednesday? ↗

December 18, 2024

Corvus Pharmaceuticals shares interim Phase 1 trial data showing promising results for soquelitinib in treating moderate to severe atopic dermatitis.

Via Benzinga

Crude Oil Gains Over 1%, General Mills Shares Fall ↗

December 18, 2024

Via Benzinga

Dow Surges 150 Points, US Current Account Deficit Widens In Q3 ↗

December 18, 2024

Via Benzinga

Topics Stocks

Heico, Corvus Pharmaceuticals, Tesla And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

December 18, 2024

Via Benzinga

US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak ↗

December 18, 2024

U.S. stock futures climbed on Wednesday as Wall Street awaits the Fed's final interest rate decision and its monetary policy forecasts for 2025.

Via Benzinga

Topics Economy Stocks

Why Corvus Pharmaceuticals Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket ↗

December 18, 2024

Via Benzinga

Stellantis, MicroStrategy, Bit Digital And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

September 30, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 30, 2024

Via Benzinga

Why Nio Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket ↗

September 30, 2024

Via Benzinga

Casella Waste Systems, SES AI And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

September 18, 2024

Via Benzinga

Topics Artificial Intelligence

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition